TB-500 for heart health in stable artery disease
Part of Heart & circulation clinical trials.
This study tests if TB-500 can improve blood markers of cardiovascular health in people with stable artery disease. It is an early-phase trial to see if the drug is safe and shows promise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have stable heart or artery disease (for example, a past heart attack more than 6 months ago, a stent or bypass, or blocked leg arteries).
- You are already on standard medications (like a statin and a blood thinner) for at least 8 weeks.
- Your blood pressure is controlled (below 160/100).
- You have not had a heart attack, stroke, or heart procedure in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced 'multi-omics' testing (looking at your genes, proteins, and other body signals) to find better ways to group people with coronary heart disease. It may help doctors understand your condition more precisely and guide future treatments.
This trial tests a new medication, AZD0780, to see if it helps prevent major cardiovascular events like heart attacks or strokes in people who already have heart or blood vessel disease, or are at high risk for a first event. It might be a good fit if your cholesterol isn't well-controlled despite current treatments.
This study tests whether a new drug called HRS9531 can help people with atherosclerotic cardiovascular disease (hardened arteries affecting the heart and blood vessels). The trial will check if it's safe and effective for managing this condition.
This study tests a new treatment, NTLA-2001, for people with a type of heart disease called transthyretin amyloidosis with cardiomyopathy. It aims to see if the medicine can help improve heart function and quality of life.
This study tests an experimental drug (RO7763505) in healthy people and people with stable heart disease. It aims to see how safe the drug is and how it works in the body.
This study tests TA-65 to see if it improves how well small blood vessels work, which can be worse with aging and coronary artery disease (CAD). You may be eligible if you’re in the right age group and meet the heart-diagnosis and health-stability requirements.
Hear when a new Endothelial Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.